Scriptr Global, Inc.
PrivateLast Round
Series A
Extension
Mar 8, 2017
Total Funding Raised
$9M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Scriptr Global, Inc. operates in Healthcare & Life Sciences and is based in Houston, Texas. Its latest recorded funding round was a Series A Extension round in March 2017.
Scriptr Global, Inc. is a biotechnology company that develops gene and RNA-based therapeutics for rare diseases using its proprietary StitchR and CirculR platforms.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Scriptr Global, Inc. Comparables
Compare Scriptr Global, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bristol Myers Squibb | 83% | |
| Tacit Therapeutics | 83% | |
| Ascidian Therapeutics | 82% |
For institutional investors. Book with your work email.
Scriptr Global, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Mar 8, 2017 | ||||
| Series A | Feb 10, 2016 |
For institutional investors. Book with your work email.
Scriptr Global, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| IM Capital | Series A Extension |
| Middle East Venture Partners | Series A Extension, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 1251% MoM, reaching 2.5K.
- Jun 18, 2026
Monthly visitors increased 46% MoM.
For institutional investors. Book with your work email.
Scriptr Global, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Scriptr Global, Inc.'s valuation, stock price, and market status.
Is Scriptr Global, Inc. a public or private company?
Scriptr Global, Inc. is a private company.
What is the current stock price of Scriptr Global, Inc.?
Scriptr Global, Inc. is a private company, so its shares have no public market price. Caplight tracks Scriptr Global, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Scriptr Global, Inc. worth (valuation)?
Valuation information for Scriptr Global, Inc. is not publicly available.
Can I buy Scriptr Global, Inc. stock?
Scriptr Global, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Scriptr Global, Inc.'s last funding round?
Scriptr Global, Inc.'s most recent funding round was Series A Extension on March 8, 2017.
Who are the main investors in Scriptr Global, Inc.?
Key investors in Scriptr Global, Inc. include Middle East Venture Partners.
Will Scriptr Global, Inc. IPO soon?
No public IPO plans have been announced for Scriptr Global, Inc..
How can I track Scriptr Global, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Scriptr Global, Inc.'s shares on secondary markets.